Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Mathis

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Acta Biomaterialia|May 23, 2008
Osteoblast interaction with DLC-coated Si substratesFeng Chai, Nicolas Mathis, Nicolas Blanchemain, et al.
Nature Protocols|August 15, 2025
Systematic pegRNA design with PRIDICT2.0 and ePRIDICT for efficient prime editingNicolas Mathis, Kim Fabiano Marquart, Ahmed Allam, et al.
The British Journal of Nutrition|February 29, 2008
Ultrastructural features of hepatocytes in cultured Eurasian perch ( Perca fluviatilis L.) as affected by nutritional and husbandry conditionsGersande Blanchard, Jean N Gardeur, Nicolas Mathis, et al.
Molecular Therapy. Nucleic Acids|October 11, 2021
Replacing the <i>Sp</i>Cas9 HNH domain by deaminases generates compact base editors with an alternative targeting scopeLukas Villiger, Lukas Schmidheini, Nicolas Mathis, et al.
BMC Medical Genetics|March 2, 2017
Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicingRamona Bolognini, Christina Gerth-Kahlert, Mathias Abegg, et al.
Nature Biotechnology|January 16, 2023
Predicting prime editing efficiency and product purity by deep learningNicolas Mathis, Ahmed Allam, Lucas Kissling, et al.
EMBO Molecular Medicine|March 10, 2020
A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogrammingMichael Cangkrama, Mateusz Wietecha, Nicolas Mathis, et al.
Nature Chemical Biology|September 21, 2023
Continuous directed evolution of a compact CjCas9 variant with broad PAM compatibilityLukas Schmidheini, Nicolas Mathis, Kim Fabiano Marquart, et al.
Science Translational Medicine|March 16, 2022
In vivo prime editing of a metabolic liver disease in miceDesirée Böck, Tanja Rothgangl, Lukas Villiger, et al.
Science Translational Medicine|May 13, 2026
Prime editing of a pathogenic <i>Scn1a</i> allele ameliorates seizure phenotypes in a GEFS<sup>+</sup> mouse modelLucas Kissling, Francesca Pietrafesa, Matteo Ranucci, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Acta Biomaterialia|May 23, 2008
Osteoblast interaction with DLC-coated Si substratesFeng Chai, Nicolas Mathis, Nicolas Blanchemain, et al.
Nature Protocols|August 15, 2025
Systematic pegRNA design with PRIDICT2.0 and ePRIDICT for efficient prime editingNicolas Mathis, Kim Fabiano Marquart, Ahmed Allam, et al.
The British Journal of Nutrition|February 29, 2008
Ultrastructural features of hepatocytes in cultured Eurasian perch ( Perca fluviatilis L.) as affected by nutritional and husbandry conditionsGersande Blanchard, Jean N Gardeur, Nicolas Mathis, et al.
Molecular Therapy. Nucleic Acids|October 11, 2021
Replacing the <i>Sp</i>Cas9 HNH domain by deaminases generates compact base editors with an alternative targeting scopeLukas Villiger, Lukas Schmidheini, Nicolas Mathis, et al.
BMC Medical Genetics|March 2, 2017
Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicingRamona Bolognini, Christina Gerth-Kahlert, Mathias Abegg, et al.
Nature Biotechnology|January 16, 2023
Predicting prime editing efficiency and product purity by deep learningNicolas Mathis, Ahmed Allam, Lucas Kissling, et al.
EMBO Molecular Medicine|March 10, 2020
A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogrammingMichael Cangkrama, Mateusz Wietecha, Nicolas Mathis, et al.
Nature Chemical Biology|September 21, 2023
Continuous directed evolution of a compact CjCas9 variant with broad PAM compatibilityLukas Schmidheini, Nicolas Mathis, Kim Fabiano Marquart, et al.
Science Translational Medicine|March 16, 2022
In vivo prime editing of a metabolic liver disease in miceDesirée Böck, Tanja Rothgangl, Lukas Villiger, et al.
Science Translational Medicine|May 13, 2026
Prime editing of a pathogenic <i>Scn1a</i> allele ameliorates seizure phenotypes in a GEFS<sup>+</sup> mouse modelLucas Kissling, Francesca Pietrafesa, Matteo Ranucci, et al.
Pageof 2